Reddit comparison threads on GHRH-T versus CJC-1295 are among the most-read peptide posts, and most of them skip the parts a laboratory buyer actually needs: what each molecule is, how the published research differs, and what to check on the certificate.
What they are
Both are synthetic analogs of growth-hormone-releasing hormone studied in preclinical and clinical research. GHRH-T is a 44-amino-acid analog with a trans-3-hexenoic acid modification; CJC-1295 is a modified 29-amino-acid fragment, available with or without the drug affinity complex (DAC) that extends its half-life in published studies. The structural difference drives the research-literature difference, which is why the two are not interchangeable in a study design.
What the threads miss
- Which CJC-1295 is meant: with DAC or without. Threads rarely say, and the two have different pharmacokinetic profiles in the literature.
- Published research context: GHRH-T has a clinical-trial literature; much of the CJC-1295 literature is earlier and smaller.
- Certificate details: molecular weight on the mass spec identity check differs between the molecules and between CJC-1295 variants, which is how you confirm which one you received.
Material pages: GHRH-T and CJC-1295. Side-by-side data: /compare. Certificates: /coas. How to read vendor threads: research peptide suppliers: what Reddit gets right and wrong.
For Research Use Only. This product is intended for laboratory and scientific research purposes only. It is not a drug or dietary supplement and is not for human or veterinary consumption.
